Rheumatology

Your Article Summary

See Latest Articles

Activity of lysosomal exoglycosidases in serum and synovial fluid in patients with chronic Lyme and rheumatoid arthritis
Scandinavian Journal of Infectious Diseases, 06/25/09

Pancewicz S et al. - The ratio of synovial fluid/serum activity of exoglycosidases was above 2.0 in LA but not in JIA and RA patients. As the main source of exoglycosidases in the joint is the synovial membrane, this result supports the appropriateness of therapeutic synovectomy in chronic Lyme arthritis with knee effusion. The serum activity of hexosaminidase may be used in monitoring the course of Lyme arthritis and the efficiency of treatment.

Today in Infectious Arthritis...keeping you current

Receive free subspecialty "5-minute updates" via email

Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09

CD23 mediates anti-mycobacterial activity of human macrophages
Infection and Immunity, 10/20/09

Arthroscopic synovectomy, an alternative in the treatment of brucellar arthritis of the knee with prolonged course. A report of two cases
The Internet Journal of Orthopedic Surgery, 10/12/09

See All of Infectious Arthritis

Today in Rheumatoid Arthritis...keeping you current

Receive free subspecialty "5-minute updates" via email

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09

Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up
Scandinavian Journal of Rheumatology , 09/28/09

See All of Rheumatoid Arthritis